Brief: Synact Pharma Proposes EGM For Share Acquisition Authorization
29/09/2025 06:55
Sept 29 (Reuters) - SynAct Pharma AB SYNACT.ST: PROPOSES EGM FOR SHARE ACQUISITION AUTHORIZATION BOARD PROPOSES ACQUISITION OF OWN SHARES UP TO SEK 10 MILLION ACQUISITION LIMITED TO 10% OF TOTAL SHARES Source text: ID:nMFN25LfG8 Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development